ReviewWorld journal of gastroenterology2008
Thrombosis and inflammatory bowel disease-the role of genetic risk factors.
Review in World journal of gastroenterology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.
- Factor V Leiden and inflammatory bowel disease: a systematic review and meta-analysis.Journal of gastroenterology · 2011Pooled it
- Arterial Thrombosis in Severe Ulcerative Colitis: A Case-Based Narrative Review of Current Evidence.Biomedicines · 2026Review
- Pathophysiological Links Between Inflammatory Bowel Disease and Cardiovascular Disease: The Role of Dysbiosis and Emerging Biomarkers.Biomedicines · 2025Review
- Successful management of dural venous sinus thrombosis secondary to ulcerative colitis in a pediatric patient: A case report.Radiology case reports · 2022Article
- Inflammatory Bowel Disease: An Indication to Screen for Thrombophilia?Diseases (Basel, Switzerland) · 2022Review
- Inflammatory bowel disease and thromboembolic events: a c'lot to learn.Therapeutic advances in gastroenterology · 2022Article
- Venous and arterial thromboembolism in patients with inflammatory bowel diseases.World journal of gastroenterology · 2021Review
- Cerebral Venous Sinus Thrombosis in Inflammatory Bowel Disease: A Review of Published Case Reports.The Permanente journal · 2021Review
- Role of Vitamin K in Intestinal Health.Frontiers in immunology · 2021Review
- Oxidative Stress and Thrombosis during Aging: The Roles of Oxidative Stress in RBCs in Venous Thrombosis.International journal of molecular sciences · 2020Review
- Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association.Acta bio-medica : Atenei Parmensis · 2018Review
- Structural brain lesions in inflammatory bowel disease.World journal of gastrointestinal pathophysiology · 2015Review
- Thrombosis in inflammatory bowel diseases: what's the link?Thrombosis journal · 2015Article
- Inflammatory bowel disease and thromboembolism.World journal of gastroenterology · 2014Review
- Venous thrombosis and prothrombotic factors in inflammatory bowel disease.World journal of gastroenterology · 2014Review
- Inflammatory bowel disease: an increased risk factor for neurologic complications.World journal of gastroenterology · 2014Review
- Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.World journal of gastroenterology · 2014Review
- Extraintestinal manifestations and complications in IBD.Nature reviews. Gastroenterology & hepatology · 2013Review
- Inflammatory bowel disease and thrombosis.Turkish journal of haematology : official journal of Turkish Society of Haematology · 2012Review
- Factor V Leiden, prothrombin 20210G>A, MTHFR 677C>T and 1298A>C, and homocysteinemia in Tunisian blood donors.Journal of clinical laboratory analysis · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thromboembolism is a significant cause of morbidity and mortality in patients with inflammatory bowel disease (IBD). Recent data suggest thromboembolism as a disease-specific extraintestinal manifestation of IBD, which is developed as the result of multiple interactions between acquired and genetic risk factors. There is evidence indicating an imbalance of procoagulant, anticoagulant and fibrinolitic factors predisposing in thrombosis in patients with IBD. The genetic factors that have been suggested to interfere in the thrombotic manifestations of IBD include factor V Leiden, factor II (prothrombin, G20210A), methylenetetrahydrofolate reductase gene mutation (MTHFR, 6777T), plasminogen activator inhibitor type 1 (PAI-1) gene mutation and factor XIII (val34leu). In this article we review the current data and future prospects on the role of genetic risk factors in the development of thromboembolism in IBD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.